SS-31

FDA APPROVAL PENDING

Well Studied

Longevity

Metabolic

Longevity

SS-31

Metabolic

Amino acid sequence

0

Amino acids

0da

Molecular weight

Peptide

Type

SS-31 (Elamipretide) is an aromatic-cationic tetrapeptide that selectively binds to cardiolipin in the inner mitochondrial membrane, preventing lipid peroxidation and optimizing electron transport chain function for enhanced cellular energy production.

Top researched benefits

Overview of SS-31

Selectively binds to cardiolipin in inner mitochondrial membrane, preventing lipid peroxidation and optimizing electron transport chain function. This improves ATP production and reduces oxidative damage at the mitochondrial level.

Mitochondrial

  • Optimizes electron transport chain function for improved cellular energy.
  • Prevents cardiolipin peroxidation and reduces mitochondrial oxidative damage.
  • Significant improvements in 6-minute walk test and fatigue scores in PMM patients.

Cardiovascular

  • Reduces cardiac injury markers and improves mitochondrial function in surgical patients.
  • Reduces ischemia-reperfusion injury and supports cardiac function.
  • Enhanced exercise capacity and reduced fatigue.

Antiaging

  • Reversed age-related decline in muscle function in animal studies.
  • Neuroprotective effects demonstrated in Alzheimer's models.
  • Supports overall cellular health through mitochondrial optimization.

Storage

Reconstituted: 2-8°C in amber/dark vials, use within 30 days. Light sensitive

Frequency

Once daily (morning or pre-workout for athletic use)

Typical Dose

5-10mg general support, 10-40mg clinical/performance protocols

Cycle Duration

4-12 weeks for therapeutic protocols

No visual available

Due to this peptide having no amino acids, there is no molecular chain to display.

Chemical Makeup

Key benefits

Directly protects mitochondria

Improves cellular energy production (ATP)

Reduces oxidative damage

Enhances exercise capacity

Excellent safety profile in clinical trials

Cardioprotective effects

Community interest

This peptide is still gaining traction in the community.

Mitochondrial-Targeted Peptide | Cardiolipin Protector

This overview is informational and based on aggregated descriptions from studies and user reports.

Was it helpful?Yes

SS-31 Molecular Information

View the scientifc details of SS-31.

Molecular Weight

0Da

Chain Length

0Amino Acids

Type

Peptide

SS-31 Protocols

Subcutaneous or intravenous injection. SS-31 dissolves readily and should be protected from light due to photosensitivity.

GoalDosageFrequencyRoute
General mitochondrial support51 week rangeSubQ
Athletic performance101 week rangeSubQ
Clinical protocols401 week rangeSubQ or IV
Acute cardioprotection0.25IV

Reconstitution Instructions

Materials needed:

SS-31 peptide vialBacteriostatic water or salineInsulin syringes (for SubQ)Alcohol prep padsSterile filter (optional for IV)Amber vials (light protection)

Steps to reconstitute

  1. Clean vial with alcohol pad
  2. Add 1-2mL bacteriostatic water per 10mg peptide
  3. Gently swirl to dissolve (dissolves readily)
  4. Verify clear, colorless solution
  5. Optional: sterile filtration for IV use
  6. Label with concentration and date
  7. Store immediately at 2-8°C
  8. Protect from light - use amber vials if available

SS-31 Cycle

The SS-31 Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.

Taking breaks between cycles may help maintain effectiveness and support better overall results.

Day 1-3
Subtle energy improvements, reduced fatigue
Week 1-2
Better exercise endurance, faster recovery
Week 2-4
Improved stamina, clearer thinking, better sleep
Week 4-8
Significant exercise capacity improvements
Week 8-12
Sustained energy, potential biomarker changes

Dosing tools

SS-31 Peptide Dosage Calculator

Calculate peptide doses with our visual syringe guide.

0.3mL / 30 units

5 units

0.050 mL

1 mL

2 mL

3 mL

5 mL

Custom

Conversion: 1,000 mcg = 1 mg

Injection Results

Based on your vial and dilution inputs.

Safe concentration range

SS-31

SINGLE COMPOUND

Volume per injection

0.05

mL

Concentration

10.00

mg/mL

Doses per vial

20

doses

Total injections per vial

20 injections

How it works

Based on a 10 mg SS-31 vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.

Research Purposes Only

These calculators are provided for educational and research purposes only. Always verify calculations and consult with qualified professionals. The information provided is not medical advice. Peptides should only be used in accordance with applicable laws and regulations.

Reference Guide

Dosing Cycle

Peptide
SS-31
Dosing
5-10mg general support, 10-40mg clinical/performance protocols
Dosing Frequency
Once daily (morning or pre-workout for athletic use)
Cycle Duration
4-12 weeks for therapeutic protocols
Storage
Reconstituted: 2-8°C in amber/dark vials, use within 30 days. Light sensitive

Note: Triple agonist; microdose for fewer side effects

Reconstitution Tips

  • Use bacteriostatic water (BAC)contains 0.9% benzyl alcohol for preservation
  • Inject water slowlyaim down the vial wall, not directly onto powder
  • Never shakegently swirl or roll the vial until dissolved
  • Store properlyrefrigerate at 2-8°C after reconstitution
  • Use within 28 daysmost reconstituted peptides remain stable for about 4 weeks
  • Keep sterilealways clean vial tops with alcohol before drawing

Peptide Interactions

Research suggestions of SS-31 interactions with other common peptides and substances.

Healing

bpc

Longevity

BPC-157

COMPATIBLE

BPC-157 focuses on tissue repair while SS-31 targets cellular energetics.

COMPATIBLE

Healing

ghk

Longevity

GHK-Cu

COMPATIBLE

Different mechanisms; no conflicts.

COMPATIBLE

Cognitive

hum

Longevity

Humanin

SYNERGISTIC

May work together to protect cellular function.

SYNERGISTIC

Longevity

mot

Metabolic

MOTS-c

SYNERGISTIC

Both are mitochondrial peptides with complementary mechanisms.

SYNERGISTIC

Longevity

nad

Metabolic

NAD+

SYNERGISTIC

Both support mitochondrial function through different mechanisms.

SYNERGISTIC

Healing

thymos

Longevity

Thymosin Beta-4

COMPATIBLE

Both cardioprotective via different pathways.

COMPATIBLE

Side effects

Contraindications

Known hypersensitivity to peptides

Pregnancy or breastfeeding (limited data)

Stop signs

Severe injection site reactions

Allergic reaction signs (rash, breathing difficulty)

Unusual fatigue or weakness (paradoxical reaction)

Cardiovascular symptoms

Severe headaches or vision changes

Bad signs

Yellow or brown discoloration indicates degradationCloudy solution or visible particlesImproper storage conditions
Was it helpful?Yes

Comments

0.0

0 reviews

5

4

3

2

1

No comments yet

Be the first to share your experience. Your review helps others make more informed decisions.

Frequently asked questions

What benefits can peptides offer in research?

Peptides can support cellular repair, immune function, metabolic health, and tissue regeneration. Research suggests they may help with recovery, sleep quality, skin health, and cognitive function, depending on the specific peptide and its mechanism of action.

What are some exciting applications of peptides in modern science?

Current research explores peptides for longevity, muscle recovery, wound healing, metabolic disorders, and neuroprotection. Scientists are also investigating peptide-based drug delivery and targeted therapies that could offer more precise treatment options.

How do peptides influence health and wellness?

Peptides work by binding to receptors on cells and triggering specific biological responses. Depending on the peptide, they may promote growth hormone release, support collagen production, modulate inflammation, or influence neurotransmitter activity—each with different implications for health and wellness.

Where can I find the latest studies on peptide applications?

Peer-reviewed journals such as Nature, Science, and specialized publications like Peptides and the Journal of Peptide Science publish ongoing research. PubMed and Google Scholar are useful for searching studies by peptide name or condition.

Are there any guidelines for using peptides in research?

Research use of peptides typically follows institutional review board (IRB) protocols and regulatory guidelines. Dosage, administration route, and safety monitoring should align with published literature and applicable regulations in your jurisdiction.

What is the difference between peptides and proteins?

Peptides are short chains of amino acids (typically under 50), while proteins are longer chains that fold into complex structures. Peptides are often more stable, easier to synthesize, and can cross cell membranes more readily, making them attractive for therapeutic applications.

How should peptides be stored?

Most peptides require refrigeration (2–8°C) and protection from light. Reconstituted peptides often have shorter stability and may need to be used within days or weeks. Always follow the manufacturer's or research protocol's storage instructions.

Can peptides be taken orally?

Some peptides are bioavailable orally, but many are broken down by digestive enzymes before reaching the bloodstream. Subcutaneous injection, nasal administration, or other routes are often used in research to improve bioavailability. The optimal route depends on the specific peptide.

SS-31Research References

SS-31 is a well studied compound

4Research references

SS-31

SS-31 is a well studied compound

Primary Mitochondrial Myopathy Phase 2 Trial

40mg daily for 12 weeks in 36 patients showed significant improvements in 6-minute walk test and fatigue scores with excellent safety profile.

2018

Cardioprotection in Heart Failure Study

0.25mg/kg/hr infusion during cardiac surgery reduced cardiac injury markers and improved mitochondrial function.

2019

Age-Related Muscle Dysfunction Study

8 weeks in aged mice reversed age-related decline in muscle function, increased ATP production, and reduced oxidative stress.

2020

Barth Syndrome Clinical Trial

Phase 3 trial with 40mg daily for 48 weeks showed trends toward cardiac improvement in this rare mitochondrial disorder.

2021